CIK 0001437402 · Large accelerated filer
ARDELYX, INC.
Sign in to watch- Ticker
- ARDX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- 510-745-7047
- Business address
- 34175 ARDENWOOD BLVD., FREMONT, CA, 94555
- Former names
- NTERYX INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $486,197
- in 8 filings
Net −$486,197. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- RAAB MICHAEL −$226K President & CEO sold 3% of stake
- Bishop John E −$76K See Remarks sold 6% of stake
- Brady James Parker −$58K Chief Human Resources Officer sold 6% of stake
- Williams Laura A −$41K Chief Patient Officer sold 3% of stake
- Foster Eric Duane −$33K Chief Commercial Officer sold 2% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −14,933 | $6.27 | $94K | 1,759,848 |
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −7,861 | $6.27 | $49K | 1,751,987 |
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −17,926 | $6.27 | $112K | 1,734,061 |
| 2026-05-21 | RAAB MICHAEL President & CEO | Sale | −14,028 | $6.27 | $88K | 1,720,033 |
| 2026-05-21 | Bishop John E See Remarks | Sale | −2,306 | $6.27 | $14K | 336,845 |
| 2026-05-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,833 | $0.99 | $21K | 1,816,447 |
| 2026-05-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,666 | $6.28 | $262K | 1,774,781 |
| 2026-05-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,833 | 332,501 | ||
| 2026-04-15 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,834 | $0.99 | $21K | 1,837,282 |
| 2026-04-15 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,668 | $6.29 | $262K | 1,795,614 |
| 2026-04-15 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,834 | 353,334 | ||
| 2026-03-16 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,833 | $0.99 | $21K | 1,856,986 |
| 2026-03-16 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,666 | $5.84 | $243K | 1,816,448 |
| 2026-03-16 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,833 | 374,168 | ||
| 2026-02-24 | RAAB MICHAEL President & CEO | Option exercise 10b5-1 | +20,833 | $0.99 | $21K | 1,877,819 |
| 2026-02-24 | RAAB MICHAEL President & CEO | Sale 10b5-1 | −41,666 | $6.26 | $261K | 1,836,153 |
| 2026-02-24 | RAAB MICHAEL President & CEO | Option exercise · Stock Option (Right to Buy) 10b5-1 | −20,833 | 395,001 | ||
| 2026-02-20 | MOTT DAVID M Director | Purchase | +333,333 | $5.84 | $1.9M | 3,302,918 |
| 2026-02-20 | Bishop John E See Remarks | Sale | −2,792 | $5.87 | $16K | 339,538 |
| 2026-02-20 | Bishop John E See Remarks | Sale | −386 | $5.71 | $2K | 339,152 |
Page 4 of 11 · 206 trades